Carisma Therapeutics Inc. Increase Decrease In Operating Lease Liability
Carisma Therapeutics Inc. reported Increase Decrease In Operating Lease Liability of -$1.63 million for the 9-month period ending 2025-09-30, per its 10-Q filed 2025-11-12.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOperatingLeaseLiability · last filed 2025-11-12
- Carisma Therapeutics Inc. increase decrease in operating lease liability for the quarter ending 2025-09-30 was -$589.00K.
- Carisma Therapeutics Inc. increase decrease in operating lease liability for the quarter ending 2025-06-30 was -$334.00K.
- Carisma Therapeutics Inc. increase decrease in operating lease liability for the quarter ending 2025-03-31 was -$707.00K.
- Carisma Therapeutics Inc. increase decrease in operating lease liability for the quarter ending 2024-12-31 was $298.00K.
- Carisma Therapeutics Inc. increase decrease in operating lease liability for fiscal 2024 was -$5.53M.
- Carisma Therapeutics Inc. increase decrease in operating lease liability for fiscal 2023 was -$4.94M.
- Carisma Therapeutics Inc. increase decrease in operating lease liability for fiscal 2022 was -$4.66M.
| Period end | Increase Decrease In Operating Lease Liability 3 month | Increase Decrease In Operating Lease Liability 6 month | Increase Decrease In Operating Lease Liability 9 month | Increase Decrease In Operating Lease Liability 12 month |
|---|---|---|---|---|
| 2025-09-30 | -$589.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | -$923.00K derived: sum of 2 quarters · filed 2025-11-12 | -$1.63M 10-Q · filed 2025-11-12 | -$1.33M derived: sum of 4 quarters · filed 2025-11-12 |
| 2025-06-30 | -$334.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07 | -$1.04M 10-Q · filed 2025-08-07 | -$743.00K derived: sum of 3 quarters · filed 2025-08-07 | -$1.95M derived: sum of 4 quarters · filed 2025-11-12 |
| 2025-03-31 | -$707.00K 10-Q · filed 2025-05-13 | -$409.00K derived: sum of 2 quarters · filed 2025-05-13 | -$1.62M derived: sum of 3 quarters · filed 2025-11-12 | -$4.88M derived: sum of 4 quarters · filed 2025-11-12 |
| 2024-12-31 | $298.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31 | -$911.00K derived: sum of 2 quarters · filed 2025-11-12 | -$4.17M derived: sum of 3 quarters · filed 2025-11-12 | -$5.53M 10-K · filed 2025-03-31 |
| 2024-09-30 | -$1.21M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | -$4.47M derived: sum of 2 quarters · filed 2025-11-12 | -$5.82M 10-Q · filed 2025-11-12 | -$7.19M derived: sum of 4 quarters · filed 2025-11-12 |
| 2024-06-30 | -$3.26M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07 | -$4.61M 10-Q · filed 2025-08-07 | -$5.98M derived: sum of 3 quarters · filed 2025-08-07 | -$7.64M derived: sum of 4 quarters · filed 2025-08-07 |
| 2024-03-31 | -$1.35M 10-Q · filed 2025-05-13 | -$2.72M derived: sum of 2 quarters · filed 2025-05-13 | -$4.38M derived: sum of 3 quarters · filed 2025-05-13 | -$5.43M derived: sum of 4 quarters · filed 2025-05-13 |
| 2023-12-31 | -$1.37M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31 | -$3.03M derived: sum of 2 quarters · filed 2025-03-31 | -$4.07M derived: sum of 3 quarters · filed 2025-03-31 | -$4.94M 10-K · filed 2025-03-31 |
| 2023-09-30 | -$1.66M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | -$2.71M derived: sum of 2 quarters · filed 2024-11-07 | -$3.57M 10-Q · filed 2024-11-07 | -$5.35M derived: sum of 4 quarters · filed 2024-11-07 |
| 2023-06-30 | -$1.05M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | -$1.92M 10-Q · filed 2024-08-08 | -$3.69M derived: sum of 3 quarters · filed 2024-08-08 | -$4.49M derived: sum of 4 quarters · filed 2024-08-08 |
| 2023-03-31 | -$868.00K 10-Q · filed 2024-05-09 | -$2.65M derived: sum of 2 quarters · filed 2024-05-09 | -$3.44M derived: sum of 3 quarters · filed 2024-05-09 | -$5.15M derived: sum of 4 quarters · filed 2024-05-09 |
| 2022-12-31 | -$1.78M derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-01 | -$2.57M derived: sum of 2 quarters · filed 2024-04-01 | -$4.28M derived: sum of 3 quarters · filed 2024-04-01 | -$4.66M 10-K · filed 2024-04-01 |
| 2022-09-30 | -$794.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | -$2.51M derived: sum of 2 quarters · filed 2023-11-09 | -$2.88M 10-Q · filed 2023-11-09 | |
| 2022-06-30 | -$1.71M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-10 | -$2.09M 10-Q · filed 2023-08-10 | ||
| 2022-03-31 | -$376.00K 10-Q · filed 2023-05-11 |